ANGO

AngioDynamics (ANGO)

AngioDynamics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ANGO

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/22	06 : 30	Business Wire	AngioDynamics Announces CE Mark Approval in Europe for AlphaVac F18⁸⁵ System	NASDAQ:ANGO	AngioDynamics Inc
2024/05/07	05 : 45	Business Wire	AngioDynamics’ APEX-AV Trial Results Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism Presented at SCAI 2024 Scientific Sessions	NASDAQ:ANGO	AngioDynamics Inc
2024/04/04	20 : 31	IH Market News	US Index Futures Rise, Oil Dips Slightly	NASDAQ:ANGO	AngioDynamics Inc
2024/04/04	20 : 00	Business Wire	AngioDynamics Reports Fiscal Year 2024 Third Quarter Financial Results; Updates Fiscal Year 2024 Guidance to Reflect Asset Divestiture	NASDAQ:ANGO	AngioDynamics Inc
2024/04/04	19 : 45	Business Wire	AngioDynamics Receives 510(k) Clearance for AlphaVac F1885 System in Treatment of PE	NASDAQ:ANGO	AngioDynamics Inc
2024/04/02	06 : 26	Business Wire	AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.	NASDAQ:ANGO	AngioDynamics Inc
2024/03/20	05 : 01	Business Wire	AngioDynamics to Report Fiscal 2024 Third Quarter Financial Results on April 4, 2024	NASDAQ:ANGO	AngioDynamics Inc
2024/03/07	06 : 01	Business Wire	AngioDynamics to Participate in a Fireside Chat at the Oppenheimer Virtual Healthcare MedTech & Services Conference	NASDAQ:ANGO	AngioDynamics Inc
2024/03/05	10 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ANGO	AngioDynamics Inc
2024/02/16	06 : 05	Business Wire	AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million	NASDAQ:ANGO	AngioDynamics Inc
2024/01/24	06 : 14	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ANGO	AngioDynamics Inc
2024/01/23	22 : 00	Business Wire	AngioDynamics Announces FDA 510(k) Clearance of Auryon XL Radial Access Catheter to Treat Peripheral Arterial Disease	NASDAQ:ANGO	AngioDynamics Inc
2024/01/22	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGO	AngioDynamics Inc
2024/01/11	21 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGO	AngioDynamics Inc
2024/01/09	06 : 47	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ANGO	AngioDynamics Inc
2024/01/05	21 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGO	AngioDynamics Inc
2024/01/05	21 : 00	Business Wire	AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance	NASDAQ:ANGO	AngioDynamics Inc
2023/12/22	06 : 01	Business Wire	AngioDynamics to Present at the J.P. Morgan Healthcare Conference	NASDAQ:ANGO	AngioDynamics Inc
2023/12/08	06 : 01	Business Wire	AngioDynamics to Report Fiscal 2024 Second Quarter Financial Results on January 5, 2024	NASDAQ:ANGO	AngioDynamics Inc
2023/12/07	22 : 00	Business Wire	AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism	NASDAQ:ANGO	AngioDynamics Inc
2023/11/07	22 : 03	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:ANGO	AngioDynamics Inc
2023/10/07	03 : 34	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ANGO	AngioDynamics Inc
2023/10/06	06 : 15	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ANGO	AngioDynamics Inc
2023/10/04	20 : 22	IH Market News	Wednesday’s Wall Street Highlights: Apple, Intel, Cal-Maine, A10 Networks, and more	NASDAQ:ANGO	AngioDynamics Inc
2023/10/04	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ANGO	AngioDynamics Inc
2023/10/04	20 : 00	Business Wire	AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance	NASDAQ:ANGO	AngioDynamics Inc
2023/09/22	10 : 28	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ANGO	AngioDynamics Inc
2023/09/22	10 : 23	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ANGO	AngioDynamics Inc
2023/09/22	10 : 17	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ANGO	AngioDynamics Inc
2023/09/22	10 : 12	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	NASDAQ:ANGO	AngioDynamics Inc